Detalles de la búsqueda
1.
Split-Dose Administration Enhances Immune Responses Elicited by a mRNA/Lipid Nanoparticle Vaccine Expressing Respiratory Syncytial Virus F Protein.
Mol Pharm
; 20(1): 279-289, 2023 01 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36251490
2.
Potent neutralizing antibodies elicited by dengue vaccine in rhesus macaque target diverse epitopes.
PLoS Pathog
; 15(6): e1007716, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31170257
3.
Low-dose penile SIVmac251 exposure of rhesus macaques infected with adenovirus type 5 (Ad5) and then immunized with a replication-defective Ad5-based SIV gag/pol/nef vaccine recapitulates the results of the phase IIb step trial of a similar HIV-1 vaccine.
J Virol
; 86(4): 2239-50, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22156519
4.
Evaluation of a stabilized RSV pre-fusion F mRNA vaccine: Preclinical studies and Phase 1 clinical testing in healthy adults.
Vaccine
; 41(44): 6488-6501, 2023 Oct 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37777449
5.
Robust, vaccine-induced CD8(+) T lymphocyte response against an out-of-frame epitope.
J Immunol
; 184(1): 67-72, 2010 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19949108
6.
Upper and lower respiratory tract correlates of protection against respiratory syncytial virus following vaccination of nonhuman primates.
Cell Host Microbe
; 30(1): 41-52.e5, 2022 01 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34879230
7.
Profiling of hMPV F-specific antibodies isolated from human memory B cells.
Nat Commun
; 13(1): 2546, 2022 05 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35538099
8.
Preclinical immunogenicity and efficacy of a candidate COVID-19 vaccine based on a vesicular stomatitis virus-SARS-CoV-2 chimera.
EBioMedicine
; 82: 104203, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35915046
9.
Synthesis and immunological activities of novel Toll-like receptor 7 and 8 agonists.
Cell Immunol
; 270(2): 126-34, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21570062
10.
Comparative analysis of immune responses induced by vaccination with SIV antigens by recombinant Ad5 vector or plasmid DNA in rhesus macaques.
Mol Ther
; 18(8): 1568-76, 2010 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-20551910
11.
Vaccine-induced cellular responses control simian immunodeficiency virus replication after heterologous challenge.
J Virol
; 83(13): 6508-21, 2009 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-19403685
12.
Synthesis and immunological activities of novel agonists of toll-like receptor 9.
Cell Immunol
; 263(1): 105-13, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20381019
13.
Modified mRNA/lipid nanoparticle-based vaccines expressing respiratory syncytial virus F protein variants are immunogenic and protective in rodent models of RSV infection.
NPJ Vaccines
; 5(1): 16, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32128257
14.
Development and application of a higher throughput RSV plaque assay by immunofluorescent imaging.
J Virol Methods
; 263: 88-95, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30381239
15.
Antibody responses to crucial functional epitopes as a novel approach to assess immunogenicity of vaccine adjuvants.
Vaccine
; 37(29): 3770-3778, 2019 06 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-31153687
16.
Immune response and reactogenicity of an unadjuvanted intradermally delivered human papillomavirus vaccine using a first generation Nanopatch™ in rhesus macaques: An exploratory, pre-clinical feasibility assessment.
Vaccine X
; 2: 100030, 2019 Aug 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31384745
17.
Characterization of potent RSV neutralizing antibodies isolated from human memory B cells and identification of diverse RSV/hMPV cross-neutralizing epitopes.
MAbs
; 11(8): 1415-1427, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31402751
18.
Design and characterization of a fusion glycoprotein vaccine for Respiratory Syncytial Virus with improved stability.
Vaccine
; 36(52): 8119-8130, 2018 12 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-30340881
19.
A novel lipid nanoparticle adjuvant significantly enhances B cell and T cell responses to sub-unit vaccine antigens.
Vaccine
; 34(1): 110-9, 2016 Jan 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-26555351
20.
Co-Administration of Lipid Nanoparticles and Sub-Unit Vaccine Antigens Is Required for Increase in Antigen-Specific Immune Responses in Mice.
Vaccines (Basel)
; 4(4)2016 Dec 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-27929422